Soft Gelatin Capsules

Soft Gelatin Capsules Market Outlook

The global soft gelatin capsules market is projected to reach approximately USD 5.2 billion by 2035, growing at a robust CAGR of around 6.5% during the forecast period from 2025 to 2035. This growth can be attributed to the increasing demand for convenient dosage forms in pharmaceutical and nutraceutical applications, driven by the rising prevalence of chronic diseases and a growing focus on preventive healthcare. Additionally, the ability of soft gelatin capsules to enhance the bioavailability of poorly soluble drugs is further propelling their adoption across various applications. The convenience of oral administration and the flexibility in formulation also contribute significantly to the market's expansion. With advancements in manufacturing technologies and a growing trend towards personalized medicine, the market is expected to witness significant advancements and innovations in product offerings.

Growth Factor of the Market

Several driving factors are contributing to the growth of the soft gelatin capsules market. First and foremost, the increasing consumer awareness regarding health and wellness is stimulating demand for nutraceuticals and dietary supplements, which are often delivered in soft gelatin forms for improved efficacy. Additionally, the growing elderly population, who often require chronic disease management, is increasingly favoring soft gelatin capsules due to their ease of swallowing and enhanced absorption capabilities. The pharmaceutical industry's shift towards more advanced drug delivery systems that utilize soft gelatin capsules is also a significant growth factor, as these capsules can accommodate a wide range of active ingredients. Furthermore, advancements in gelatin and non-gelatin polymer technologies enable manufacturers to create more customized formulations, catering to specific consumer needs. The rise of e-commerce in recent years has also made these products more accessible to consumers, thereby boosting the market's growth. Finally, increasing investments in research and development aimed at improving the properties and performance of soft gelatin capsules will continue to drive market dynamics.

Key Highlights of the Market

• The global soft gelatin capsules market is projected to reach USD 5.2 billion by 2035.
• North America holds the largest market share, attributed to a robust pharmaceutical sector.
• Gelatin soft capsules are expected to dominate the product type segment due to their long-standing presence in the market.
• The pharmaceuticals application segment is anticipated to witness significant growth owing to rising medication usage.
• Online retail channels are rapidly gaining popularity, making soft gelatin capsules more accessible to consumers.

By Product Type

Gelatin Soft Capsules:

Gelatin soft capsules continue to dominate the soft gelatin capsules market due to their long-established presence and widespread acceptance in both the pharmaceuticals and nutraceuticals sectors. These capsules are made from animal-derived gelatin, which provides an excellent barrier to oxygen and moisture, ensuring the stability of sensitive substances. Their ability to encapsulate a wide variety of formulations, including oils, powders, and even certain liquids, presents a versatile manufacturing option for companies. As a result, gelatin soft capsules are favored for delivering vitamins, herbal extracts, and various nutraceutical ingredients where enhanced bioavailability is crucial. Additionally, their smooth texture enhances consumer compliance, making them a preferred choice among patients and consumers alike.

Non-Gelatin Soft Capsules:

Non-gelatin soft capsules are gaining traction in the market, catering to the growing demand for vegetarian and vegan alternatives. Made from materials such as hydroxypropyl methylcellulose (HPMC) or pullulan, these capsules offer similar bioavailability benefits as their gelatin counterparts. They are particularly appealing to health-conscious consumers and those with dietary restrictions, further driving their adoption in the nutraceutical and dietary supplement sectors. The pharmaceutical industry is also recognizing the potential of non-gelatin capsules for encapsulating sensitive compounds and formulations that are incompatible with gelatin. As the trend toward plant-based ingredients continues to grow, the non-gelatin segment is expected to experience notable expansion in the coming years.

By Application

Pharmaceuticals:

The pharmaceuticals application segment is the largest contributor to the soft gelatin capsules market, accounting for a significant share due to the extensive usage of these capsules in medication formulations. Soft gelatin capsules are preferred for encapsulating liquid formulations, including oils, which are often used in modern pharmacotherapy. Their ability to mask unpleasant tastes and odors makes them ideal for pediatric and geriatric patients who may have difficulty with traditional dosage forms. Additionally, the trend towards personalized medicine is pushing pharmaceutical companies to innovate their delivery systems, and soft gelatin capsules provide the flexibility and customization needed to meet these emerging demands. With ongoing developments in drug formulation technologies, the pharmaceuticals application is projected to maintain its growth momentum.

Nutraceuticals:

The nutraceuticals application segment is witnessing remarkable growth, driven by the rising consumer interest in health supplements and dietary products. Soft gelatin capsules are widely utilized for encapsulating vitamins, omega-3 fatty acids, herbal extracts, and other nutritional compounds that require enhanced absorption. The convenience of taking soft gelatin capsules, combined with their ability to deliver concentrated doses of active ingredients, aligns with the increasing focus on preventive healthcare and wellness. Furthermore, innovations in formulation techniques are enabling manufacturers to create multi-layered soft gelatin capsules that combine various nutrients in a single dosage form. The growing trend towards self-medication and health management is expected to further bolster the demand for soft gelatin capsules in the nutraceuticals sector.

Cosmeceuticals:

In recent years, the cosmeceuticals application of soft gelatin capsules has gained momentum due to increasing consumer awareness of skincare and wellness products. These capsules are employed to encapsulate active ingredients that offer skin benefits, such as antioxidants and vitamins. The convenience of soft gelatin capsules, along with their ability to preserve the integrity of sensitive compounds, has positioned them as a preferred choice in the beauty and skincare industry. As consumers increasingly seek internal health products that also promise external beauty benefits, the soft gelatin capsules market in the cosmeceuticals segment is expected to witness significant growth. Brands are also leveraging soft gelatin capsules for innovative product offerings, such as beauty supplements that promise significant advantages for skin, hair, and nails.

Sports Nutrition:

The sports nutrition sector is another significant application area for soft gelatin capsules, driven by the growing fitness culture and demand for performance-enhancing supplements. These capsules are popular for encapsulating protein powders, amino acids, and other performance-boosting nutrients that athletes and fitness enthusiasts seek to enhance their physical performance and recovery. The ease of consumption and precise dosing offered by soft gelatin capsules makes them particularly appealing in this segment. Moreover, the trend towards personalized nutrition is prompting manufacturers to explore innovative formulations that cater specifically to athletes’ needs, further driving the demand for soft gelatin capsules in sports nutrition. As the awareness of health and fitness continues to rise globally, this segment is expected to exhibit substantial growth in the coming years.

Others:

The 'Others' category includes various niche applications where soft gelatin capsules are utilized, including but not limited to veterinary medicines and specialty health products. Given the versatility of soft gelatin capsules, they have found utility in segments that require specialized formulations, such as delivery systems for certain types of vaccines and specialized dietary products for pets. The growing awareness of animal health and the increasing expenditure on pet care are likely to drive demand in this segment. Additionally, as new applications for soft gelatin capsules are explored through research and development, this segment is anticipated to expand further. The potential to address unique health needs through soft gelatin capsules opens avenues for innovation and expansion in the overall market.

By Distribution Channel

Pharmacies:

Pharmacies remain one of the foremost distribution channels for soft gelatin capsules, playing a critical role in the market due to their accessibility and consumer trust. Pharmacists often recommend soft gelatin capsules for various health concerns, leading to a steady demand within this sector. The ability to provide personalized consultations makes pharmacies an essential touchpoint for consumers seeking advice on medication and supplements. The growing number of community pharmacies, coupled with their commitment to patient health, enhances the distribution of soft gelatin capsules, particularly in regions with a high prevalence of chronic diseases. As healthcare systems continue to evolve, pharmacies are expected to play an even more integral role in driving market growth through the distribution of effective and reliable health products.

Drug Stores:

Drug stores also represent a significant distribution channel for soft gelatin capsules, particularly in regions where they serve as primary points of access for consumers seeking health and wellness products. These stores typically offer a wide range of over-the-counter (OTC) supplements and pharmaceuticals, making it convenient for consumers to find soft gelatin capsules for their health needs. Drug stores often feature promotional campaigns and discounts that attract health-conscious consumers and drive sales. In addition, the staff in drug stores are often trained to provide guidance on the benefits and uses of various supplements, thus helping to enhance product visibility and consumer education. The growth of chain drug stores and their ability to stock diverse product offerings are projected to positively influence the distribution of soft gelatin capsules.

Online Retail:

Online retail has emerged as a rapidly growing distribution channel for soft gelatin capsules, significantly revolutionizing how consumers access health and wellness products. The convenience of shopping from home, coupled with the ability to compare prices and read reviews, has made online platforms increasingly popular among consumers. E-commerce giants, as well as niche health-focused online retailers, are expanding their product offerings, including a diverse range of soft gelatin capsules. Furthermore, the COVID-19 pandemic accelerated the shift towards online shopping, leading to increased consumer confidence in purchasing health products online. This trend is expected to persist, as advancements in e-commerce technologies and logistics continue to enhance the overall shopping experience for consumers. As a result, the online retail segment is anticipated to contribute significantly to the growth of the soft gelatin capsules market.

Supermarkets/Hypermarkets:

Supermarkets and hypermarkets are also vital distribution channels for soft gelatin capsules, offering a wide selection of health and wellness products under one roof. These large retail outlets typically feature designated health sections that attract consumers looking for vitamins, dietary supplements, and pharmaceuticals. The visibility of soft gelatin capsules in supermarkets and hypermarkets, coupled with promotional strategies such as discounts and loyalty programs, helps drive sales in this segment. Furthermore, the trend of health and wellness shopping is on the rise, encouraging supermarkets to expand their offerings in this category to meet consumer demand. As these retail formats continue to evolve and adapt to changing consumer behaviors, the potential for soft gelatin capsules to capture market share in supermarkets and hypermarkets will remain strong.

Others:

The 'Others' category in the distribution channel segment encompasses various unconventional channels such as health food stores, specialty retailers, and direct sales. These channels play a crucial role in reaching niche consumer segments that seek specific health products tailored to their needs. Health food stores often cater to a clientele that prioritizes natural and organic supplements, thus creating a unique market for soft gelatin capsules that align with these preferences. Specialty retailers and direct sales also offer personalized shopping experiences, allowing consumers to receive tailored recommendations based on individual health goals. The growth of alternative distribution channels is likely to contribute to the overall expansion of the soft gelatin capsules market as consumer preferences continue to diversify.

By Ingredient Type

Gelatin:

Gelatin remains the most widely used ingredient type in the production of soft gelatin capsules, primarily due to its favorable properties and long history of use in the pharmaceutical and nutraceutical industries. Derived from animal collagen, gelatin provides excellent film-forming capabilities and creates a desirable texture that enhances consumer acceptance. Furthermore, gelatin capsules are known for their rapid dissolution properties, which allow for quick absorption of active ingredients in the gastrointestinal tract. The versatility of gelatin also enables pharmaceutical companies to encapsulate a variety of formulations, including oils and powders, thus meeting diverse consumer needs. Although there is a growing trend towards plant-based alternatives, gelatin continues to dominate the ingredient type segment due to its established reliability and performance.

Non-Gelatin Polymers:

The inclusion of non-gelatin polymers in the soft gelatin capsules market has gained traction in response to the rising demand for vegetarian and vegan-friendly products. Materials such as hydroxypropyl methylcellulose (HPMC) and pullulan are becoming increasingly popular as alternatives to gelatin, offering similar encapsulation benefits without the use of animal-derived ingredients. This shift towards non-gelatin polymers is particularly relevant in regions with a significant vegetarian population or where consumers demand plant-based options. Non-gelatin capsules provide the flexibility to accommodate oil-based and powder formulations while maintaining stability and bioavailability. As consumer preferences continue to evolve, the non-gelatin polymers segment is expected to witness substantial growth, catering to a wider audience with diverse dietary needs.

By Region

The soft gelatin capsules market is experiencing varying growth dynamics across different regions, with North America leading the charge. The North American market is expected to reach approximately USD 2.1 billion by 2035, driven by a robust pharmaceutical sector that heavily utilizes soft gelatin capsules for drug delivery. The increasing prevalence of chronic diseases, coupled with the growing consumer inclination towards dietary supplements, is further fostering market growth in this region. Moreover, the presence of key industry players and ongoing R&D efforts aimed at developing innovative soft gelatin formulations are likely to sustain this momentum. The market is projected to grow at a CAGR of 6.8%, underscoring North America’s strong position as a prominent player in the global soft gelatin capsules market.

Europe is another critical region in the soft gelatin capsules market, contributing a significant share due to the growing demand for nutraceuticals and cosmeceuticals. The European market is anticipated to reach approximately USD 1.5 billion by 2035, bolstered by increasing consumer awareness regarding health and wellness. The presence of well-established pharmaceutical companies and a strong retail infrastructure further support growth in this region. Asia Pacific is also emerging as a potential growth hub, with the market projected to reach USD 1.2 billion by 2035, driven by the rising population, increased healthcare expenditures, and growing disposable incomes. This region is expected to witness a notable CAGR of 7.2%, indicating the burgeoning opportunities for soft gelatin capsules, particularly in the nutraceuticals sector.

Opportunities

The soft gelatin capsules market is poised for substantial growth, fueled by various opportunities that present themselves in the evolving healthcare landscape. One of the most significant opportunities lies in the increasing consumer focus on preventive healthcare and wellness. With more individuals prioritizing their health and wellbeing, the demand for dietary supplements and nutraceuticals is on the rise. This trend encourages formulators to innovate and create new soft gelatin capsule products that cater to specific health needs, such as immune support, weight management, and cardiovascular health. Furthermore, the growing acceptance of personalized and customized health solutions presents an exciting avenue for manufacturers to develop tailor-made soft gelatin capsules, enhancing their appeal to a broader consumer base. Companies that leverage these opportunities to align their products with changing consumer demands stand to gain a competitive edge in the market.

Moreover, the rise of e-commerce is transforming the retail landscape, providing manufacturers with a direct channel to reach consumers with their soft gelatin capsule products. The convenience, accessibility, and extensive range of products available online are encouraging consumers to explore health supplements more actively. This growth in online retail channels offers a lucrative opportunity for manufacturers to invest in digital marketing strategies and enhance their online presence. Expanding distribution through online platforms allows companies to tap into new consumer segments and geographic markets, driving sales and brand awareness. By capitalizing on the growing trend of online shopping, businesses can ensure their products reach a wider audience and meet the increasing demand for soft gelatin capsules.

Threats

Despite the promising growth prospects, the soft gelatin capsules market faces several threats that could impact its trajectory. One of the primary threats is the increasing competition from alternative dosage forms, such as tablets and capsules made from non-gelatin materials. As consumer preferences shift toward vegetarian and vegan-friendly products, manufacturers may find it challenging to retain market share if they do not adapt to these changing demands. Additionally, the rising cost of raw materials, particularly gelatin, poses a potential risk for manufacturers who rely on animal-derived ingredients. This, coupled with stringent regulations regarding the quality and safety of dietary supplements and pharmaceuticals, can complicate the production process and increase operational costs. Companies must remain vigilant and agile in responding to these market dynamics to mitigate potential risks and maintain competitiveness.

Another significant threat to the soft gelatin capsules market is the growing trend of health-conscious consumers who prefer natural and organic products. There is an increasing skepticism towards synthetic additives and artificial ingredients, prompting consumers to seek out clean-label products. This shift could pressure manufacturers to reformulate existing products or invest in new technologies to meet evolving consumer preferences. Furthermore, the possibility of regulatory changes regarding the labeling and marketing of dietary supplements and pharmaceuticals could affect how products are positioned in the market. To navigate through these potential threats, companies must focus on innovation, transparency, and adherence to regulatory standards to build trust and maintain relevance in the marketplace.

Competitor Outlook

• Pfizer Inc.
• Capsugel (now part of Lonza Group)
• Lonza Group Ltd.
• Eurofins Scientific SE
• Kaystar Pharmaceutical Packaging
• Ginkgo BioWorks
• Rottendorf Pharma GmbH
• Amgen Inc.
• Soft Gel Technologies, Inc.
• BASF SE
• Natural Capsules Limited
• Qualicaps LLC
• GMP Pharmaceuticals
• HPM Global
• Robinson Pharma, Inc.

The competitive landscape of the soft gelatin capsules market is characterized by a mix of established pharmaceutical companies and specialized contract manufacturers. Key players in this space leverage their extensive research and development capabilities to innovate and introduce new products that address shifting consumer preferences and market demands. Companies such as Pfizer Inc. and Amgen Inc. dominate the pharmaceuticals sector, utilizing soft gelatin capsules for their diverse product portfolios. Their established distribution networks and brand recognition provide them with a competitive advantage in reaching a broad audience and maintaining market leadership.

Lonza Group, known for its manufacturing of high-quality soft gelatin capsules, has positioned itself as a leader in the industry. The acquisition of Capsugel has further enhanced its capabilities, allowing it to offer a comprehensive range of soft gelatin solutions tailored to the pharmaceutical and nutraceutical markets. Eurofins Scientific SE is another prominent player that focuses on quality control and testing, ensuring that soft gelatin capsules meet the rigorous standards set by regulatory authorities. Such companies contribute significantly to the overall market dynamics by maintaining high-quality standards and ensuring compliance with safety regulations.

In addition to these established players, numerous contract manufacturers such as Soft Gel Technologies, Inc. and Rottendorf Pharma GmbH are emerging as vital contributors to the market. These companies specialize in the production of customized soft gelatin capsules, enabling brands to develop unique formulations tailored to their target audiences. As the demand for personalized health solutions continues to rise, the role of contract manufacturers will become increasingly important in providing flexibility and innovation in product offerings. Overall, the competitive landscape of the soft gelatin capsules market is expected to evolve as companies continue to adapt to changing consumer preferences, technological advancements, and regulatory requirements.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 BASF SE
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 Amgen Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 HPM Global
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Pfizer Inc.
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Qualicaps LLC
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Ginkgo BioWorks
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Lonza Group Ltd.
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 GMP Pharmaceuticals
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Robinson Pharma, Inc.
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Eurofins Scientific SE
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Rottendorf Pharma GmbH
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 Natural Capsules Limited
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Soft Gel Technologies, Inc.
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Kaystar Pharmaceutical Packaging
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Capsugel (now part of Lonza Group)
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Soft Gelatin Capsules Market, By Application
    • 6.1.1 Pharmaceuticals
    • 6.1.2 Nutraceuticals
    • 6.1.3 Cosmeceuticals
    • 6.1.4 Sports Nutrition
    • 6.1.5 Others
  • 6.2 Soft Gelatin Capsules Market, By Product Type
    • 6.2.1 Gelatin Soft Capsules
    • 6.2.2 Non-Gelatin Soft Capsules
  • 6.3 Soft Gelatin Capsules Market, By Ingredient Type
    • 6.3.1 Gelatin
    • 6.3.2 Non-Gelatin Polymers
  • 6.4 Soft Gelatin Capsules Market, By Distribution Channel
    • 6.4.1 Pharmacies
    • 6.4.2 Drug Stores
    • 6.4.3 Online Retail
    • 6.4.4 Supermarkets/Hypermarkets
    • 6.4.5 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Soft Gelatin Capsules Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Soft Gelatin Capsules market is categorized based on

By Product Type

• Gelatin Soft Capsules
• Non-Gelatin Soft Capsules

By Application

• Pharmaceuticals
• Nutraceuticals
• Cosmeceuticals
• Sports Nutrition
• Others

By Distribution Channel

• Pharmacies
• Drug Stores
• Online Retail
• Supermarkets/Hypermarkets
• Others

By Ingredient Type

• Gelatin
• Non-Gelatin Polymers

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Pfizer Inc.
• Capsugel (now part of Lonza Group)
• Lonza Group Ltd.
• Eurofins Scientific SE
• Kaystar Pharmaceutical Packaging
• Ginkgo BioWorks
• Rottendorf Pharma GmbH
• Amgen Inc.
• Soft Gel Technologies, Inc.
• BASF SE
• Natural Capsules Limited
• Qualicaps LLC
• GMP Pharmaceuticals
• HPM Global
• Robinson Pharma, Inc.